» Articles » PMID: 29114283

A Method for Reconstruction of Severely Damaged Spinal Cord Using Autologous Hematopoietic Stem Cells and Platelet-rich Protein As a Biological Scaffold

Overview
Specialty Neurology
Date 2017 Nov 9
PMID 29114283
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: There have been attempts to alter the prognosis of severe spinal cord injury in different centers, but none of which have reliably altered the outcome. Some trials use stem cells (SCs) that produced widely differing results. We hereby add our experience in our center of a surgical reconstruction of the damaged spinal cord using a mixture of SCs and Platelet-Rich Protein (PRP) with fibrin coated as a biological scaffold.

Materials And Methods: Four cases of severely damaged spinal cord have been operated for neurolysis and reconstruction of the spinal cord using SCs and platelet-rich protein (PRP) with fibrin coated harvested from the peripheral circulation of the patient. PRP serves to maintain the position of the SCs. One milliliter suspension contains an average of 2.8 × 10 of autologous hematopoietic SCs. Patients were intraoperatively monitored by somatosensory evoked potential, motor evoked potentials, and delta wave. They are clinically followed postoperatively and electromyogram was repeated every 2 weeks. Magnetic resonance imaging (MRI) was repeated regularly. The patients are followed up for a period between 2 and 3 years.

Results: One patient demonstrated motor and objective sensory improvement ( = 0.05), two other patients reported subjective sensory improvement, and the fourth one remained without any improvement ( = 0.1). None of these patients demonstrated any sign of deterioration or complication either on the surgery or on implanting of the SCs. MRI clearly proved that the inserted biological scaffold remained in place of reconstruction.

Conclusion: SCs may play a role in restoring spinal cord functions. However, the unsolved problems of the use of SCs and related ethical issues should be addressed.

Citing Articles

An Insight into the Prospects and Drawbacks of Stem Cell Therapy for Spinal Cord Injuries: Ongoing Trials and Future Directions.

Khan S, Ahmed N, Ahsan K, Abbasi M, Maugeri R, Chowdhury D Brain Sci. 2023; 13(12).

PMID: 38137145 PMC: 10741986. DOI: 10.3390/brainsci13121697.


Molecular Mechanisms and Clinical Application of Multipotent Stem Cells for Spinal Cord Injury.

Szymoniuk M, Litak J, Sakwa L, Dryla A, Zezulinski W, Czyzewski W Cells. 2023; 12(1).

PMID: 36611914 PMC: 9818156. DOI: 10.3390/cells12010120.


Effect of Platelet-Rich Plasma on Intervertebral Disc Degeneration and : A Critical Review.

Chang Y, Yang M, Ke S, Zhang Y, Xu G, Li Z Oxid Med Cell Longev. 2020; 2020:8893819.

PMID: 33299533 PMC: 7704139. DOI: 10.1155/2020/8893819.


Progress in Stem Cell Therapy for Spinal Cord Injury.

Gao L, Peng Y, Xu W, He P, Li T, Lu X Stem Cells Int. 2020; 2020:2853650.

PMID: 33204276 PMC: 7661146. DOI: 10.1155/2020/2853650.


Combined administration of platelet rich plasma and autologous bone marrow aspirate concentrate for spinal cord injury: a descriptive case series.

Shehadi J, Elzein S, Beery P, Spalding M, Pershing M Neural Regen Res. 2020; 16(2):362-366.

PMID: 32859799 PMC: 7896202. DOI: 10.4103/1673-5374.290903.

References
1.
Masaka T, Miyazaki M, Du G, Hardjo M, Sakaguchi M, Takaishi M . Derivation of hepato-pancreatic intermediate progenitor cells from a clonal mesenchymal stem cell line of rat bone marrow origin. Int J Mol Med. 2008; 22(4):447-52. View

2.
Alberti E, Los M, Garcia R, Fraga J, Serrano T, Hernandez E . Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesions. Med Sci Monit. 2009; 15(2):BR47-54. View

3.
Khazaei M, Ahuja C, Fehlings M . Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury. Front Cell Dev Biol. 2017; 4:152. PMC: 5243807. DOI: 10.3389/fcell.2016.00152. View

4.
Chamberlain J, Schwarze U, Wang P, Hirata R, Hankenson K, Pace J . Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science. 2004; 303(5661):1198-201. DOI: 10.1126/science.1088757. View

5.
Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K . Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine (Phila Pa 1976). 2005; 30(21):2379-87. DOI: 10.1097/01.brs.0000184365.28481.e3. View